<div id="readability-page-1"><div><div>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.<ul> <li>Morgan Stanley raised Acuity Inc. (NYSE:AYI) price target from $365 to $425. Morgan Stanley analyst Christopher Snyder maintained an Overweight rating. Acuity shares closed at $363.00 on Wednesday. See how other analysts view this stock.</li> <li>Deutsche Bank raised the price target for Norfolk Southern Corporation (NYSE:NSC) from $290 to $354. Deutsche Bank analyst Richa Harnain maintained a Buy rating. Norfolk Southern shares closed at $298.68 on Wednesday. See how other analysts view this stock.</li> <li>B of A Securities boosted T. Rowe Price Group, Inc. (NASDAQ:TROW) price target from $91 to $97. B of A Securities analyst Craig Siegenthaler maintained an Underperform rating. T. Rowe Price shares closed at $101.07 on Wednesday. See how other analysts view this stock.</li> <li>Citigroup raised the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from $550 to $575. Citigroup analyst Geoff Meacham maintained a Buy rating. Vertex Pharmaceuticals shares closed at $404.21 on Wednesday. See how other analysts view this stock.</li> <li>Goldman Sachs cut the price target for Keurig Dr Pepper Inc. (NASDAQ:KDP) from $34 to $29. Goldman Sachs analyst Bonnie Herzog maintained a Neutral rating. Keurig Dr Pepper shares closed at $25.60 on Wednesday. See how other analysts view this stock.</li> <li>Piper Sandler slashed Kimberly-Clark Corporation (NASDAQ:KMB) price target from $149 to $145. Piper Sandler analyst Michael Lavery maintained an Overweight rating. Kimberly-Clark shares settled at $123.23 on Wednesday. See how other analysts view this stock.</li> <li>Goldman Sachs cut Colgate-Palmolive Company (NYSE:CL) price target from $106 to $91. Goldman Sachs analyst Jason English maintained a Buy rating. Colgate-Palmolive shares closed at $79.01 on Wednesday. See how other analysts view this stock.</li> <li>B of A Securities raised Robinhood Markets, Inc. (NASDAQ:HOOD) price target from $139 to $157. B of A Securities analyst Craig Siegenthaler maintained a Buy rating. Robinhood shares closed at $139.14 on Wednesday. See how other analysts view this stock.</li> <li>Stifel raised the price target for Levi Strauss &amp; Co. (NYSE:LEVI) from $24 to $27. Stifel analyst Jim Duffy maintained a Buy rating. Levi Strauss shares settled at $24.40 on Wednesday. See how other analysts view this stock.</li> <li>Morgan Stanley raised Apple Inc. (NASDAQ:AAPL) price target from $240 to $298. Morgan Stanley analyst Erik Woodring maintained an Overweight rating. Apple shares closed at $255.45 on Wednesday. See how other analysts view this stock.</li> </ul>Considering buying AAPL stock? Here’s what analysts think: Read This Next:<ul> <li> Wall Street’s Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields</li> </ul>Photo via Shutterstock</div></div></div>

AAPL

Top Wall Street analysts have revised their price targets for several companies. Morgan Stanley raised Apple Inc.'s target from $240 to $298, maintaining an Overweight rating. Other notable changes include Acuity Inc. (from $365 to $425), Norfolk Southern Corporation (from $290 to $354), and Vertex Pharmaceuticals (from $550 to $575). Conversely, Goldman Sachs cut targets for Keurig Dr Pepper (from $34 to $29) and Colgate-Palmolive (from $106 to $91). Overall, analysts are optimistic about several stocks while adjusting their forecasts accordingly.

- Top Wall Street analysts have revised their price targets for several companies, reflecting changes in their outlook.  
- Morgan Stanley raised the price target for Acuity Inc. from $365 to $425, while Deutsche Bank increased Norfolk Southern's target from $290 to $354.  
- Other notable changes include Citigroup raising Vertex Pharmaceuticals' target from $550 to $575 and Goldman Sachs cutting Keurig Dr Pepper's target from $34 to $29.

Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Thursday